Evoke Pharma Inc (EVOK:NASDAQ) Investor Relations Material

Overview

Solana Beach-based specialty pharmaceutical company, Evoke Pharma, Inc., is dedicated to tackling gastroenterological disorders and diseases through the development and commercialization of innovative drugs. The company's flagship product, Gimoti, is a metoclopramide nasal spray designed to alleviate the symptoms associated with acute and recurrent diabetic gastroparesis in adults. Evoke Pharma's target audience includes gastroenterologists, primary care physicians, and select healthcare providers. Established in 2007, Evoke Pharma, Inc. has established itself as a key player in the pharmaceutical industry.

Frequently Asked Questions

What is Evoke Pharma Inc's ticker?

Evoke Pharma Inc's ticker is EVOK

What exchange is Evoke Pharma Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Evoke Pharma Inc's headquarters?

They are based in Solona Beach, California

How many employees does Evoke Pharma Inc have?

There are 1-10 employees working at Evoke Pharma Inc

What is Evoke Pharma Inc's website?

It is evokepharma.com

What type of sector is Evoke Pharma Inc?

Evoke Pharma Inc is in the Healthcare sector

What type of industry is Evoke Pharma Inc?

Evoke Pharma Inc is in the Drugs - Generic industry

Who are Evoke Pharma Inc's peers and competitors?

The following five companies are Evoke Pharma Inc's industry peers:

- Diplomat Pharmacy

- Flexion Therapeutics Inc

- Lipocine Inc.

- Karyopharm Therapeutics

- Agile Therapeutics